Radar › Companies › Life Sciences · Thuringia
Radar · Life Sciences in Thuringia

Best Life Sciences Companies in Thuringia, Germany

The 35 best Life Sciences companies in Thuringia, Germany in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: InflaRx.

35companies tracked
$84.1Mdisclosed funding
0unicorns
14have raised
FLIAR INTELLIGENCE · LIFE SCIENCES × THURINGIA

Our analysis of 50 Life Sciences companies

$3.3b in tracked funding; 51% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2024.

50companies analysed
51%cloud-native stacks
2024funding peak (by rounds)
2016median founding year
40median Fliar Index™

Ranked: Best Life Sciences companies in Thuringia

#CompanyDisclosed fundingLast roundStageFounderFoundedTech stackPatents & IP focusRecent signals
1InflaRx
Developer of antibody therapeutics for inflammatory and immune diseases
$64M107 mo agoPublicRenfeng Guo
Co-Founder
2008OpenSSLBootstrapApache HTTP Server+10152 patents
C5a complement receptor antagonists and related small‑molecule therapeutics.
—
2eZono
Developer of ultrasound systems and needle guidance technology for clinical use
$10M164 mo agoSeries AEliseo Sobrino
Founder And Cto
2004—74 patents
Image-guided medical instrument processing and ultrasound navigation systems
—
3Microfluidic ChipShop
Provides microfluidic lab-on-chip systems
$3M92 mo agoFunding Raised—2002WordPressMySQLPHP+2443 patents
Microfluidic fluid handling and sample transfer devices for precise liquid dispensing
—
4Preventicus
Developer of medical technologies and care programs for heart health
$3M61 mo agoSeries A—2013WordPressApple iCloud MailMicrosoft 365+2730 patents
Real-time physiological monitoring and analysis of biometric data for health diagnostics.
—
5Oncgnostics
Developer of epigenetic biomarkers for cancer detection and diagnosis
$1M36 mo agoPublic—2012WordPressMySQLPHP+2322 patents
Molecular biomarker-based diagnostics and risk assessment for head and neck cancers
—
6ALS Automated Lab Solutions
Provider of single cell and colony isolation system
$1M68 mo agoAcquired—1998—45 patents
Patents concentrated in transport & manufacturing processes
—
7Askion
Equipment and devices for Life Science research
$593K140 mo agoSeries ALutz Doms
Founder
2004WordPressMySQLPHP+1933 patents
Automated laboratory sample tube handling, gripping, and cryogenic storage systems
—
8Senova
Immuno assay systems
$193K78 mo agoFunding RaisedHans Hermann Soffing
Founder
2006———
9Redwave Medical
Developer of central blood pressure monitoring device
$113K93 mo agoSeedVerena Dittrich
Co-Founder & CEO
2017—17 patents
Automated blood pressure devices and invasive pulse‑wave hemodynamic monitoring systems
—

Top 12 Life Sciences companies in Thuringia

#1
Public · Jena, Thuringia · founded 2012 · 12 employees
$1.4Mraised
▾

Developer of epigenetic biomarkers for cancer detection and diagnosis. The company offers GynTect that enables the detection of methylated DNA regions in precancerous and carcinoma cells. These marker regions are detected using PCR-based technologies.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 909 LinkedIn followers — 3.1% of this cohort's audience
Funding rounds
  • Sep 2023Series B—
  • 2018Series A$868.5K
  • 2016Series A$553.6K
  • Jan 2015Series A—
Investors
Sparkasse Jena-Saale-Holzland, STIFT, Beteiligungsmanagement Thuringen, HTGF, Seedmatch, Balmung Capital
Tech stack
WordpressMysqlPhpChart.JsBootstrapThe Events Calendar
#2
Series A · Jena, Thuringia · founded 2013 · 26 employees
$3.1Mraised
▾

Developer of medical technologies and care programs for heart health. It provides tools for heart rhythm monitoring and analysis. The company offers programs integrating technology with medical support. It focuses on preventative care and management of cardiovascular conditions.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 1k LinkedIn followers — 5.0% of this cohort's audience
Activity: 1 product launches announced in 12 mo
Funding rounds
  • Jul 2021Grant (prize money)$59.4K
  • Mar 2021Grant (prize money)$246.9K
  • Nov 2018Grant (prize money)$2.8M
  • 2016Series A—
Investors
EIC Fund, Cascara Ventures, Born2Grow, HTGF, Europa, Flying Health
Tech stack
Apple Icloud MailBackbone.JsBorlabs CookieCdnjsCloudflareContact Form 7
#3
Public · Jena, Thuringia · founded 2008 · 56 employees
$64.1Mraised
▾

Developer of antibody therapeutics for inflammatory and immune diseases. The company focuses on the development of monoclonal antibodies that target activation products of the complement system for application in inflammatory diseases. The product pipeline inlcudes Vilobelimab for oncology, immuno-dermatology, and inflammatory diseases, and IFX002 C5a Inhibitor for chronic inflammatory and autoimmune diseases.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 3k LinkedIn followers — 11.5% of this cohort's audience
Funding rounds
  • Oct 2017Series D$30M
  • Jul 2016Series C$34.1M
  • Jul 2014Series B—
  • Mar 2009Series A—
Founders & team
Renfeng GuoCo-Founder
Investors
aasa, Beteiligungsmanagement Thuringen, RA Capital Management, Bain Capital Life Sciences, Cormorant Asset Management
Tech stack
Apache Http ServerBootstrapCdnjsCloudflareCookiebotIsotope
#4
Funding Raised · Jena, Thuringia · founded 2002
$3.4Mraised
▾

Provides microfluidic lab-on-chip systems. The company's products include capillary electrophoresis chips, micromixers, nanoliter plates, fluidic interfaces, fluidic platforms, and polymer substrates. The company also develops custom solutions for miniaturization of their biological and diagnostic tasks like transfer of biological assays on the chip, the development of PCR protocols for chip-based applications, and others.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 6k LinkedIn followers — 19.5% of this cohort's audience
Activity: 1 partnerships (incl. USC and TNO) announced in 12 mo
Funding rounds
  • Jan 2019Grant (prize money)$305.1K
  • Oct 2017Grant (prize money)$613.9K
  • Jan 2017Grant (prize money)$548.7K
  • Jan 2017Grant (prize money)$422.7K
Investors
Europa
Tech stack
Apache Http ServerBootstrapContact Form 7CookieyesDatatablesFont Awesome
#5
Acquired · Jena, Thuringia · founded 1998 · 27 employees
$1.1Mraised
▾

Als-jena is a provider of single-cell and colony isolation system. The company provides automated single cell, cluster, adherent cells, colony isolation systems. The product portfolio includes CellCelector, Incubator FlowBox, and automation components.

Funding rounds
  • Jan 2021Grant (prize money)$447.2K
  • Jan 2018Grant (prize money)$660.2K
Investors
Europa
Tech stack
Website X5PhpApache Http ServerJqueryCookiebotSectigo
#6
Series A · Jena, Thuringia · founded 2004 · 21 employees
$10Mraised
▾

Developer of ultrasound systems and needle guidance technology for clinical use. The company provides solutions for anesthesia, pain therapy, musculoskeletal applications, and emergency medicine. It offers ultrasound systems, accessories, simulation software, and training materials. The company aims to improve diagnostic and treatment outcomes with its technologies.

Funding rounds
  • Jan 2013Series A$10M
Founders & team
Eliseo SobrinoFounder And Cto
Investors
MVM, Beteiligungsmanagement Thuringen
#7
Funding Raised · Erfurt, Thuringia · founded 2006 · 37 employees
$193.2Kraised
▾

Senova is engaged in developing, manufacturing, and marketing immunological test platforms for research and rapid tests to detect microorganisms, viruses, hormones, haptens, biological agents and other analytes. Additionally, the company offers custom assay development services and lyophillization services.

Funding rounds
  • Mar 2020Grant (prize money)$193.2K
Founders & team
Hans Hermann SoffingFounder
Investors
Europa
Tech stack
Outlook Web AppWindows ServerMicrosoft Asp.NetIis
#8
Series A · Gera, Thuringia · founded 2004 · 51 employees
$592.8Kraised
▾

Askion is an OEM partner for life science research companies and is focused on development, manufacturing, and service of medical and bio analytical devices as well as optoelectronics and fine mechanic optical modules for various applications. The also manufactures and sells its own line of biobanking equipment under the Askion C-Line brand, which includes hermetic storage units, internal and external automation systems, work bench, and control systems.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 2k LinkedIn followers — 5.3% of this cohort's audience
Funding rounds
  • Jan 2015Grant (prize money)$592.8K
  • Mar 2006Series A—
Founders & team
Lutz DomsFounder
Investors
Europa, SHS
Tech stack
Apache Http ServerAutoptimizeComplianzCore-JsElementorGoogle Analytics
#9
Seed · Jena, Thuringia · founded 2017 · 8 employees
$113.5Kraised
▾

Developer of central blood pressure monitoring device. The devices measure the central blood pressure at home with the help of Antares algorithms that process the oscillometric pressure curves and determine the pulse wave velocity. The device helps in the detection and therapy of high blood pressure and also determines vascular function and vascular age.

Funding rounds
  • Nov 2018Grant (prize money)$56.9K
  • Jun 2018Grant (prize money)$56.6K
  • Aug 2017Seed—
Founders & team
Verena DittrichCo-Founder & CEOChris StockmannCo-Founder & CTO
Investors
Europa, EIC Fund, Beteiligungsmanagement Thuringen, STIFT, Sparkasse Jena-Saale-Holzland, MBG
Tech stack
Cart FunctionalityWordpressMysqlPhpVarnishYoast Seo
#10
Series A · Jena, Thuringia · founded 2018 · 12 employees
—raised
▾

Developer of organ-on-chip models and contract research services for preclinical studies. The company provides immunocompetent organ models that reproduce human biology for clinical outcomes and disease insights. It offers a system that enables physiological cell and tissue culture to reproduce standard organ models. The company’s services include toxicology screenings, lead identification, and in vitro model development.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 4k LinkedIn followers — 13.6% of this cohort's audience
Activity: 1 product launches announced in 12 mo
Funding rounds
  • Jun 2023Series A—
  • Jul 2019Seed—
Founders & team
Knut RennertCo-FounderNancy MollerCo-FounderMartin RaaschCo-Founder & CEO
Investors
Beteiligungsmanagement Thuringen, MBG, Sparkasse
Tech stack
A3 Lazy LoadAnimate.CssApple Icloud MailBootstrapChart.JsComplianz
#11
Series A · Jena, Thuringia · founded 2016
—raised
▾

Developer of biotechnological methods and equipment for animal breeding improvement. It focuses on improving livestock breeding results through sperm separation techniques. The business aims to improve animal welfare and reduce environmental impact. It develops technologies for sustainable and targeted resource use in animal husbandry.

Funding rounds
  • Jan 2022Series A—
  • Dec 2018Series A—
Founders & team
M ReichenbachManaging Director
Investors
Beteiligungsmanagement Thuringen, Sparkasse Jena-Saale-Holzland, Treuenburg, SUPRAMAT
#12
Series A · Jena, Thuringia · founded 2012 · 6 employees
—raised
▾

Novapump is developing non-invasive and percutaneous heart assist devices especially for right heart insufficiency. The company's products PERKAT is a self-expanding heart pump that can be implanted within minutes in case of an emergency and represents a solution to help critically ill patients with acute right heart insufficiencies more rapidly. The small diameter of PERKAT™ allows percutaneous implantation in only a few minutes through the leg vein via Seldinger technique and using an 18F sheath system. The PERKAT device can be implanted percutaneously with no need for surgical intervention therefore saving the patient additional strain. In 2015, NovaPump was awarded by a jury as one of the most exciting young life-science project concepts 2015 and was one of the winning concepts at the VentureLounge from CatCap in Munich.

Funding rounds
  • Jun 2020Series A—
  • Dec 2015Series A—
  • Jul 2013Seed—
Founders & team
Ronald ReichFounder & CEO
Investors
HTGF, Beteiligungsmanagement Thuringen, Sparkasse Jena-Saale-Holzland

Funding & investor landscape

$84.1Mtotal disclosed funding
9companies funded
21disclosed rounds
0rounds last 90 days
Most active investors
Beteiligungsmanagement Thuringen12 rounds
Europa6 rounds
Sparkasse Jena-Saale-Holzland4 rounds
HTGF3 rounds
EIC Fund2 rounds
MBG2 rounds
STIFT2 rounds
Bain Capital Life Sciences1 rounds
Balmung Capital1 rounds
Born2Grow1 rounds

Notable founders

Renfeng Guo
Co-Founder · InflaRx
Eliseo Sobrino
Founder And Cto · eZono
Hans Hermann Soffing
Founder · Senova
Lutz Doms
Founder · Askion
Verena Dittrich
Co-Founder & CEO · Redwave Medical
Chris Stockmann
Co-Founder & CTO · Redwave Medical
Knut Rennert
Co-Founder · Dynamic42
Nancy Moller
Co-Founder · Dynamic42
M Reichenbach
Managing Director · TrophoSYS
Ronald Reich
Founder & CEO · Novapump
Christian Stange
Co-Founder · QInstruments
Prism market signals · Germany · country-scoped Prism corpus, 141,341 docs

Market landscape — 10 sub-themes by coverage

Share of Life Sciences coverage by sub-theme.

Regulatory-risk over time rising

Funding & growth over time

funding rising · growth rising

RESEARCH SIGNALS · Germany

How research on Biotechnology is moving in Germany

A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 1,297 Germany-affiliated papers.

research sentiment over time
200820152026
enthusiastic · positive · guarded tone
Tone is overwhelmingly optimistic and intensifying — the enthusiastic (strongly-positive) share moved 38% → 41% across 2008–2026.
top research entities
  • Heidelberg University85
  • German Cancer Research Center49
  • Ludwig-Maximilians-Universität München48
  • Technical University of Munich43
  • Karlsruhe Institute of Technology33
leading researchers
Lennart Hilbert · Henry Reyer · Michael Oster · Nares Trakooljul · Badhe, Pravin · Avon Augustin Nalpadan · Siriluck Ponsuksili · Ralf Nauen
▲ Breakthroughs421 · 32%
▼ 35%→31% share
▼0.9× share momentum0 median citations78% since 2021mostly empirical
Breakthroughs are cooling (35%→31% of field), led by Gene.
rising sub-themes (early→recent)
  • Gene3→29
  • Mutant3→19
  • Transcription (linguistics)3→16
  • Messenger RNA1→14
  • Immune system1→12
Newly emergingGenome 0→15 · Mutation 0→13 · RNA polymerase II 0→9
Landmark The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets · 4,863 cites
◆ Advancements429 · 33%
33%→33% share
▲1.0× share momentum0 median citations82% since 2021mostly empirical
Advancements are cooling (33%→33% of field), led by Gene.
rising sub-themes (early→recent)
  • Gene3→20
  • Agriculture2→12
  • Extracellular1→11
  • Immune system1→11
  • Transcriptome1→9
Newly emergingDownregulation and upregulation 0→12 · Selection (genetic algorithm) 0→11 · Antibody 0→10
Landmark Regulation of the Voltage Gated K<sup>+</sup> Channel K<sub>v1.3</sub> by Recombinant Human Klot · 5,606 cites
▼ Concerns184 · 14%
▼ 17%→14% share
▼0.8× share momentum0 median citations79% since 2021mostly empirical
Concerns are cooling (17%→14% of field), led by Antibiotic resistance.
rising sub-themes (early→recent)
  • Antibiotic resistance2→9
  • Gene1→7
  • Agriculture4→9
  • Antimicrobial1→4
  • Microbiome1→4
Newly emergingContext (archaeology) 0→11 · Sustainability 0→9 · Production (economics) 0→7
Landmark Prebiotic effects: metabolic and health benefits · 2,037 cites
RESEARCH HOTSPOTS · Germany

Where biotechnology is researched across Germany

Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.

Munich119 · +0.49
Hot · In vivoAdvancing · Messenger RNAOpportunity · In vitroConcern · Broiler
Berlin91 · +0.38
Hot · T cellAdvancing · Cytotoxic T cellOpportunity · In vitroConcern · Production (economics)
Heidelberg90 · +0.52
Hot · GliomaAdvancing · Cancer researchOpportunity · Gene
Jülich/Bonn72 · +0.41
Hot · Innate immune systemAdvancing · AntimicrobialOpportunity · Interferon
Karlsruhe34 · +0.30
Hot · PolymeraseAdvancing · GenomicsOpportunity · Zebrafish
Aachen23 · +0.51
Hot · Flow cytometryOpportunity · Cell culture
Dresden22 · +0.54
Opportunity · Cell culture
Stuttgart7 · +0.56
Opportunity · DNA methylation
PATENT SIGNAL · Germany

Who's filing biotechnology patents in Germany

Germany biotechnology patent filing is cooling — 53,233 filings from 8,000 assignees (2016–2025), led by Immatics Biotechnologies, BASF Plant Science, BASF SE; annual filings 4819→4267.

53,233 filings8,000 assigneespeak 6040/yr2016–2025
filing momentum (YoY 2016–2025)
top patent filers
  • Immatics Biotechnologies4872
  • BASF Plant Science3982
  • BASF SE3543
  • Boehringer Ingelheim INT3438
  • Merck Patent3133
  • MAX Planck Gesellschaft1799
  • Evonik Degussa1680
  • Amgen RES Munich1665

Common questions

How many Life Sciences companies are there in Thuringia, Germany?
Radar tracks 35 indexable Life Sciences companies headquartered in Thuringia, Germany that meet our profile-completeness bar.
What is the total funding raised by Life Sciences companies in Thuringia, Germany?
The Life Sciences companies in Thuringia, Germany on this list have raised a combined $84.1M in disclosed equity funding across 9 funded companies.
Which is the highest-funded Life Sciences company in Thuringia, Germany?
InflaRx is the highest-funded Life Sciences company in Thuringia, Germany, with $64.1M in disclosed equity funding.
How many Life Sciences companies in Thuringia, Germany are funded?
9 of the 35 Life Sciences companies in Thuringia, Germany on this list have disclosed at least one equity funding round.
How many Life Sciences unicorns are there in Thuringia, Germany?
None of the Life Sciences companies in Thuringia, Germany on this list currently has a disclosed valuation of $1B or more.
Who are the top investors in Thuringia, Germany Life Sciences companies?
The most active investors in Thuringia, Germany Life Sciences companies on this list include Beteiligungsmanagement Thuringen, Europa, Sparkasse Jena-Saale-Holzland, HTGF, EIC Fund.
Rohit KhannaTrends & Stories

Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.

Coming soon